These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 10727454)
1. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling. Teague TK; Schaefer BC; Hildeman D; Bender J; Mitchell T; Kappler JW; Marrack P J Exp Med; 2000 Mar; 191(6):915-26. PubMed ID: 10727454 [TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391 [TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. Williams L; Bradley L; Smith A; Foxwell B J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368 [TBL] [Abstract][Full Text] [Related]
4. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585 [TBL] [Abstract][Full Text] [Related]
5. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646 [TBL] [Abstract][Full Text] [Related]
6. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. Ahmed ST; Ivashkiv LB J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. Li S; Chen S; Xu X; Sundstedt A; Paulsson KM; Anderson P; Karlsson S; Sjögren HO; Wang P J Exp Med; 2000 Mar; 191(6):985-94. PubMed ID: 10727460 [TBL] [Abstract][Full Text] [Related]
9. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. Sun R; Tian Z; Kulkarni S; Gao B J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309 [TBL] [Abstract][Full Text] [Related]
10. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274 [TBL] [Abstract][Full Text] [Related]
11. Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. Van De Wiele CJ; Marino JH; Murray BW; Vo SS; Whetsell ME; Teague TK J Immunol; 2004 Apr; 172(7):4235-44. PubMed ID: 15034036 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Chen T; Wang LH; Farrar WL Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism. Shen X; Tian Z; Holtzman MJ; Gao B Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of a new STAT-induced STAT inhibitor. Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Delgado M; Ganea D J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815 [TBL] [Abstract][Full Text] [Related]
19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030 [TBL] [Abstract][Full Text] [Related]
20. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]